•  
  •  
  •  
  •  

2025-10-02 17:47:47

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue

Keywords Selected:  EvereadyIndustriesIndia

Stock Report

  • Eveready forays into Mobile Accessories Segment
  • India's No.1 Flashlight Manufacturer Eveready Industries Receives BIS Certification For TEFCO Facility
  • Eveready Industries India Ltd posts consolidated PAT of Rs. 29.36 crores in Q1 FY25
  • Eveready Industries India Ltd recommends dividend of Rs. 1
  • Eveready Industries India Ltd consolidated Q4 FY2024 PAT at Rs. 8.05 crores
  • Eveready sets New Benchmark at Maddur Plant with 55% Female Workforce
  • Eveready Industries India Ltd Q1 FY2023-24 consolidated net profit increases to Rs. 24.86 crores
  • Eveready unveils digital film 'Hero Banne Ka Power' for its Rechargeable Torches, India's fastest charging torch
  • Eveready Industries India Ltd posts consolidated loss of Rs. 14.39 crores in Q4FY23
  • Eveready Industries India Ltd Q3 FY2023 consolidated PAT declines to Rs. 5.44 crores
  • Eveready Industries India Ltd Q2 FY2023 consolidated PAT at Rs. 14.73 crores
  • Eveready Industries India Ltd Q1FY23 consolidated PAT up QoQ at Rs. 21.85 crores
  • Eveready Industries India posts loss of Rs. 38.41 crores in Q4FY22
  • Eveready Industries India Ltd appoints Mr. Suvamoy Saha as MD
  • Eveready Industries India Ltd announces resignation of Chairman and MD
  • Eveready Industries India Q3FY22 consolidated PAT slides to Rs. 23.71 crores
  • Eveready Industries India Ltd consolidated Q2FY22 PAT at Rs. 31.04 crore

Latest Post

  • Hero MotoCorp Ltd dispatches 687,220 units in September 2025
  • Synbiotics Ltd's Amphotericin B Manufacturing Facility receives USFDA approval
  • Veefin has successfully integrated CRIF's Strategy One BRE with our no-code Digital Lending Stack
  • Sentynl Therapeutics updates on its NDA for CUTX-101
  • Unimech Aerospace and Manufacturing Ltd experiences slowdown in revenue


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024